The Pharmacy Times® Cardiovascular Health Resource Center is a comprehensive resource for clinical news and expert insights on the health of the heart and blood vessels, including coronary heart disease, stroke, heart failure, heart arrhythmias, and heart valve issues.
April 22nd 2024
Investigators found that 89% of individuals with cardiovascular disease consumed more than 1500 mg of sodium daily.
Recent Advances in Omega-3 Fatty Acids to Reduce Risk of ASCVD in Patients With Elevated Triglyceride Levels
0.75 Credit / Cardiology
View More
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Introduction to Anticoagulation and the Appropriate Patient
1.0 Credit / Cardiology
View More
The Treatment Landscape and a Review of Approved DOAC Agents
1.0 Credit / Cardiology
View More
Maximizing Patient Outcomes Through Pharmacist-Led Homozygous Familial Hypercholesterolemia Management
1.0 Credit / Cardiology
View More
Setting the Stage: An Introduction to Worsening Heart Failure Events in Patients With Heart Failure With Reduced Ejection Fraction
1.0 Credit / Cardiology
View More
Navigating the Therapeutic Landscape of Homozygous Familial Hypercholesterolemia
1.0 Credit / Cardiology
View More
Understanding the Challenges of Homozygous Familial Hypercholesterolemia
1.0 Credit / Cardiology
View More
The Role of the Pharmacist in Optimizing DOAC Utilization Across Practice Settings
1.0 Credit / Cardiology
View More
Soluble Guanylate Cyclase Stimulators in the Management of Worsening Heart Failure With Reduced Ejection Fraction
1.0 Credit / Cardiology
View More
Individualizing Care for Patients With Heart Failure: The Role of the Pharmacist in Optimizing Education and Improving Adherence
1.0 Credit / Cardiology
View More
Advancing Chronic Worsening Heart Failure Treatment: The Critical Role of Pharmacists in Therapy Integration
1.0 Credit / Cardiology
View More
Iron Deficiency and Anemia in Heart Failure: Clinical Applications for the Use of Intravenous Iron
1.5 Credits / Cardiology
View More
Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure with Preserved Ejection Fraction
1.0 Credits / Cardiology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Pharmacists' Heart Risks Worsening Despite Health Expertise
February 5th 2015Despite having adequate knowledge on cardiovascular risk factors, pharmacists and other health care professionals showed significant increases in systemic arterial hypertension and excessive weight gain across a 20-year study.
Read More
One In Three People Would Risk Shorter Life Rather Than Take Daily Pill To Avoid Heart Disease
February 3rd 2015One in three people say they would risk living a shorter life instead of taking a daily pill to prevent cardiovascular disease, according to new research inCirculation: Cardiovascular Quality and Outcomes.
Read More
Which Atrial Fibrillation Patients Are Most Likely to Misreport Symptoms?
January 30th 2015A primary goal of managing atrial fibrillation is relief of symptoms that include dizziness, fatigue, palpitations, shortness of breath, and chest pain. Yet, it is symptomless in up to one-third of patients.
Read More
Study Affirms Safety of Anti-Clotting Drug
January 17th 2015Preliminary results of an ongoing post-marketing study examining Janssen Pharmaceuticals' rivaroxaban (Xarelto) in patients with non-valvular atrial fibrillation (NVAF) indicate that the anti-clotting drug's safety in real-world settings is consistent with the findings of previous phase 3 clinical trials.
Read More
Can an Aspirin a Day Keep Post-Atrial Fibrillation Clots Away?
January 7th 2015Roughly 50 million Americans take daily low-dose aspirin for cardioprevention, as it is generally perceived as a safe, effective, and inexpensive OTC preventive medication for cardiovascular disease. For patients who have nonvalvular atrial fibrillation, many guidelines recommend aspirin as thromboprophylaxis among those who are not considered to be high risk.
Read More
New, Personalized Online Community Helps Patients Live With Dangerous Heart Rhythm
December 11th 2014Many people experience a slight quivering or racing heart at some point and usually give it little notice. But for those diagnosed with atrial fibrillation, that irregular heartbeat can be a serious condition that can increase the risk of stroke and needs medical attention.
Read More
Cardiovascular Nutritional Supplements
December 8th 2014Various health organizations promote the importance of maintaining cardiovascular health because cardiovascular disease (CVD) is the leading cause of death among both men and women in the United States and the number of individuals with CVD continues to escalate annually.
Read More
Mild Coronary Artery Disease Puts Diabetics at Cardiovascular Risk
December 8th 2014New study results dispute the belief that diabetic patients with mild or non-obstructive coronary artery disease have a lower risk of major adverse cardiovascular events and death than their counterparts with obstructive disease.
Read More
Kynamro Reduces Risk of Cardiovascular Events in Familial Hypercholesterolemia Patients
November 19th 2014A Genzyme and Isis Pharmaceuticals Inc. study suggests that mipomersen sodium injections reduce the odds of major adverse cardiovascular events in patients with familial hypercholesterolemia, compared with the 2 years prior to therapy.
Read More
FDA Finds Increased Death Risk With Dual Antiplatelet Therapy
November 17th 2014The FDA is taking a look at a trial that showed 30 months of dual antiplatelet blood-thinning therapy decreased the risk of heart attack and clot formation in stents, yet increased the overall risk of death compared with 12 months of the treatment.
Read More